These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11481622)

  • 41. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
    Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years.
    Cooper CL; Angel JB; Seguin I; Davis HL; Cameron DW
    Clin Infect Dis; 2008 Apr; 46(8):1310-4. PubMed ID: 18444872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adults.
    Van Damme P; von Sonnenburg F; Hatz C; Hoet B; Lefevre I; Leyssen M
    J Med Virol; 2009 Oct; 81(10):1710-5. PubMed ID: 19697416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.
    Van der Wielen M; Van Damme P; Chlibek R; Smetana J; von Sonnenburg F
    Vaccine; 2006 Jun; 24(26):5509-15. PubMed ID: 16725234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity of Twinrix in older adults: a critical analysis.
    Stoffel M; Lievens M; Dieussaert I; Martin I; André F
    Expert Rev Vaccines; 2003 Feb; 2(1):9-14. PubMed ID: 12901592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.
    Halperin SA; Dobson S; McNeil S; Langley JM; Smith B; McCall-Sani R; Levitt D; Nest GV; Gennevois D; Eiden JJ
    Vaccine; 2006 Jan; 24(1):20-6. PubMed ID: 16198027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update: expanded availability of thimerosal preservative-free hepatitis B vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jul; 49(28):642, 651. PubMed ID: 10926308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Engerix-B hepatitis B vaccine (recombinant)/Smith, Kline & French.
    Swartz ML
    Gastroenterol Nurs; 1991; 13(3):158-61. PubMed ID: 1825929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical development of a new recombinant DNA hepatitis B vaccine.
    Safary A; André F
    Postgrad Med J; 1987; 63 Suppl 2():105-7. PubMed ID: 3317343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response of Egyptian infants with protein calorie malnutrition to hepatitis B vaccination.
    el-Gamal Y; Aly RH; Hossny E; Afify E; el-Taliawy D
    J Trop Pediatr; 1996 Jun; 42(3):144-5. PubMed ID: 8699579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specifications and quality control of a yeast-derived hepatitis B vaccine.
    Peetermans JH
    Postgrad Med J; 1987; 63 Suppl 2():97-100. PubMed ID: 3317364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update.
    Lee GH; Lim SG
    Expert Rev Vaccines; 2021 May; 20(5):487-495. PubMed ID: 33783302
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hepatitis vaccination].
    Zachoval R; Deinhardt F
    Z Gastroenterol Verh; 1982 Apr; 17():110-6. PubMed ID: 6191454
    [No Abstract]   [Full Text] [Related]  

  • 56. Immune response to hepatitis B vaccination in the mentally retarded.
    Wahl M; Hermodsson S; Iwarson S
    Scand J Infect Dis Suppl; 1983; 38():24-7. PubMed ID: 6580723
    [No Abstract]   [Full Text] [Related]  

  • 57. [Vaccination against hepatitis B. Review and prospects].
    Burette A
    Rev Med Brux; 1984 Jun; 5(6):373-83. PubMed ID: 6385192
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prospects in the specific prevention of type B viral hepatitis].
    Ionescu-Matiu I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1977; 22(1):1-8. PubMed ID: 141080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Limited success of hepatitis B vaccination?].
    Brune D; Dirks HP
    Dtsch Med Wochenschr; 1984 Jul; 109(28-29):1136. PubMed ID: 6745112
    [No Abstract]   [Full Text] [Related]  

  • 60. [A study on the immunogenicity, safety and protective efficacy of a plasma-derived hepatitis B vaccine made in China].
    Nie J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Dec; 9(6):332-5. PubMed ID: 3073016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.